← FDA DRUG APPROVALS

FDA ANDA · ANDA040749

BENZONATATE

Sponsor: THEPHARMANETWORK LLC

APPLICATION
ANDA040749
TYPE
ANDA
ORIGINAL APPROVAL
2007-07-25
LATEST ACTION
2015-01-16
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription

Products

BENZONATATEPrescription
BENZONATATE 200MG · CAPSULE · ORAL

Approval history

2015-01-16Labeling · Supplement 1 · standardAP
2007-07-25OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →